[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Assuta Ashdod Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":125},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,70,97],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100621586","effect-of-voiding-position-standing-in-the-shower-vs-sitting-on-post-void-residual-urine-volume-pvr-after-removal-of-urinary-catheter-in-women-following-benign-vaginal-gynecologic-surgery-100621586",false,"NCT07372547","Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery","Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery: A Double-Blind Randomized Controlled Trial","Inclusion Criteria:\n\n* Adult women (≥18 years old).\n* Undergoing benign vaginal gynecologic surgery with indwelling catheter during surgery.\n* No bladder injury during surgery.\n* Ability and willingness to consent.\n* No known neurological or urinary conditions affecting voiding.\n* No active urinary tract infection at time of catheter removal.\n\nExclusion Criteria:\n\n* Bladder injury during surgery.\n* Neurological disease affecting bladder function.\n* Active urinary tract infection.\n* Inability to void either standing in shower or sitting (depending on randomization).","FEMALE","18 Years","99 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.",[27,28,29,30,31],"Post-void Residual Volume","Recatheterization","Pain","UTI","Urinary Retention","RECRUITING","2026-03-22",{"date":35,"type":36},"2026-03-25","ACTUAL",{"date":38,"type":36},"2026-01-20",{"date":40,"type":21},"2028-01-20",{"name":42,"class":43},"Assuta Ashdod Hospital","OTHER",2,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},"100595807","screening-for-fibromyalgia-among-patients-with-suspected-endometriosis-100595807","NCT07037251","Screening for Fibromyalgia Among Patients With Suspected Endometriosis","Inclusion Criteria:\n\n* All women with suspected endometriosis in their first visit to endometriosis clinics in Assuta Ashdod Hospital\n\nExclusion Criteria:\n\n* Proven fibromyalgia prior to the first visit.",{"count":52,"type":21},150,"OBSERVATIONAL","The main purposes of the study are:\n\nTo determine the prevalence of fibromyalgia among patients with suspected endometriosis during their initial visit to an endometriosis clinic.\n\nSecondary aims include staging of endometriosis in these patients according to the AAGL (16,17) endometriosis classification and correlate the prevalence of fibromyalgia with ultrasound and surgical findings. Another aim will be to assess the improvement in symptoms in patients diagnosed with both disorders in comparison to patients with either one separately.\n\nAll women with suspected endometriosis will be asked to complete the questionnaire before their first visit to the doctor's office.\n\nStudy design\n\n* A single center prospective cohort study\n* All patients attending to Endometriosis clinic at Assuta Ashdod University Hospital with suspected endometriosis at initial visit and who will consent and able to sign the consent form for participation.\n* Fibromyalgia will be defined by the ACR Preliminary Diagnostic Criteria, including Widespread Pain Index, Symptoms severity scale and somatic symptoms.\n* The treating physician will blinded to questionnaire results until the end of the visit.\n* At the end of the visit the questionnaire will be analyzed by one of the investigators and if fibromyalgia is found, the patient will also be referred for treatment of this disorder along with the endometriosis treatment.\n* Questionnaires will be coded with numbers from 1 to 150.",[56,57],"Fibromyalgia","Endometriosis",[59,60],"fibromialgia","endometriosis","2025-06-23",{"date":63,"type":36},"2025-06-25",{"date":65,"type":36},"2024-07-01",{"date":67,"type":21},"2027-05",{"name":42,"class":43},1,{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":78,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":88,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":4},"100552139","oxytocin-effectiveness-in-first-trimester-dilatation-and-curettage-100552139","NCT06469203","Oxytocin Effectiveness in First Trimester Dilatation and Curettage","Inclusion Criteria:\n\n* All patients admitted to the OBGYN Assuta Ashdod Hospital for elective surgical termination of pregnancy due to missed miscarriages in the first trimester, with gestational age range of 6.0 to 11.6 weeks.\n\nPatients aged 18 years and older who are capable to provide informed consent.\n\nExclusion Criteria:\n\n* individual intolerance to oxytocin\n* mullerian anomalies\n* Fibroid uterus\n* thrombophilia or coagulation disorders\n* cardiovascular disease",{"count":77,"type":21},160,[24],"The aim of this study is to investigate the impact of oxytocin on perioperative blood loss during the D\\&C procedure, as well as to assess early and late complications associated with it's use.",[81],"Missed Abortion",[83,84,85,86,87],"missed abortion","vaginal bleeding","dilation and curretage","pregnancy termination","oxytocin","NOT_YET_RECRUITING","2024-08-12",{"date":91,"type":36},"2024-08-13",{"date":93,"type":21},"2024-09-01",{"date":95,"type":21},"2026-06",{"name":42,"class":43},{"id":98,"slug":99,"hasResults":11,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":4,"eligibilityCriteria":103,"healthyVolunteers":104,"sex":16,"minAge":105,"maxAge":106,"enrollmentInfo":107,"targetDuration":4,"studyType":22,"phases":109,"briefSummary":111,"conditions":112,"keywords":114,"overallStatus":88,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":69},"100519914","phase-4-use-of-misoprostol-in-hysteroscopic-myomectomy-100519914","NCT06049745","Use of Misoprostol in Hysteroscopic Myomectomy","Use of Misoprostol in Hysteroscopic Myomectomy, a Randomized Peospective Trial","Inclusion Criteria:\n\n* women between the ags of 20 years- 55 years, inclusive\n* undergoing hysteroscopic myomectomy\n* submucosal fibroid less than 40 mm (type 0, 1 and 2)\n* up to 2 submucosal fibroids\n* patients are able to provide written informed consent\n\nExclusion Criteria:\n\n* post menopausal women\n* inability to perform operative hysteroscopy under anesthesia in the past due to cervical stenosis\n* previous PID or documented tubal occlusion\n* positive BHCG test\n* inability to consent due to cognitive or language barrier\n* allergy to misoprostole\n* severe COPD, asthma or cardiac disease",true,"20 Years","55 Years",{"count":108,"type":21},200,[110],"PHASE4","Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.",[113],"Hysteroscopic Myomectomy",[115,116],"hysteroscopic myomectomy","misoprostol","2023-09-16",{"date":119,"type":36},"2023-09-22",{"date":121,"type":21},"2023-11",{"date":123,"type":21},"2026-10",{"name":42,"class":43},""]